Overview
- The company reported record second-quarter revenue of $234 million and a record backlog of $2.36 billion, reflecting about 62% year-over-year growth and more than 90 missions booked, according to filings and market reports.
- Management guided Q3 GAAP gross margins to 29%–31% and forecast an adjusted EBITDA loss, a step down from Street margin expectations that triggered a sharp pre-market share drop of roughly 9% on the earnings reaction.
- Rocket Lab said it still targets getting Neutron’s first-stage tank to the launch pad in Q4 but cautioned the window for an end-of-year maiden flight is narrowing, language that makes the first launch date uncertain rather than confirmed.
- The company has been spending heavily while integrating acquisitions such as Mynaric and Motiv and pursuing a proposed ~$8 billion Iridium deal; that transaction and recent insider sales disclosed at about $362.8 million have raised investor concerns about dilution and complexity.
- Large U.S. defense awards worth roughly $663 million and fresh commercial bookings strengthen near-term revenue visibility, but the firm remains unprofitable and dependent on timely Neutron progress and margin improvement for its long-term value case.